JUN 29, 2018 11:02 AM PDT

The Drug That's Best for Both Kidney Failure and Arrhythmia Patients

WRITTEN BY: Kara Marker

A specific drug is the best to prescribe to people with both an irregular heartbeat and kidney failure. This population of people is at a particularly high risk of blood clots and stroke, making a safe blood-thinning treatment – a lot of the times – the difference between life and death.

Researchers from the University of Michigan conducted a study to produce the first data to show that a drug called apixaban is safer than warfarin for the population of people with both atrial fibrillation (AF) and kidney failure. Blood-thinning drugs are routinely prescribed to treat AF, a condition characterized by an irregular heartbeat. AF is the most common type of heart arrhythmia, and it increases the risk of stroke, as blood is not pumped effectively out of the heart and to tissues all over the body.

Blood-thinning drugs like warfarin reduce the risk of blood clots, lowering the chances of a stroke, but for people with both AF and kidney failure (requiring dialysis), choosing the right blood-thinning drug can be a challenge for the physician.

When prescribing blood-thinning drugs for AF and kidney failure patients undergoing regular dialysis, physicians have to factor in that dialysis patients are almost always excluded from clinical trials conducted for the sole purpose of testing how effective and safe new treatments are. Plus, blood-thinning drugs like warfarin run the risk of major bleeding even for people without kidney failure.

Dialysis filters the blood in place of the kidneys: removing waste, salt, and extra water to prevent buildup, regulating levels of certain chemicals (potassium, sodium, bicarbonate), and helping control blood pressure.

"Patients on dialysis are one of the most challenging populations, because they have many comorbid conditions, are often on many prescription drugs and are at significant risk of kidney failure associated and treatment-related adverse events," explained senior co-author Rajiv Saran, MD. "Dialysis patients were excluded from all randomized trials that established the utility of the newer anticoagulants.”

The drug that has proved to be the best for people with both AF and kidney failure is apixaban (AKA Eliquis), an anticoagulant (blood thinner). "We found patients on apixaban had a significantly lower risk of major bleeding [30 percent less than warfarin] with no difference in stroke, which is what we try to prevent by prescribing these anticoagulants,” explained first author Konstantinos Siontis, MD.

Apixaban was first approved by the U.S. Food and Drug Administration (FDA) in 2013 to lower the risk of stroke and systemic embolism (blood clots) for people with AF. Researchers conducted their data analysis using information from more than 25,000 Medicare beneficiaries.

It’s important for the population of people with both AF and kidney failure to have access to a safe blood-thinning treatment.

"Atrial fibrillation is a pretty significant determinant of adverse outcomes in this population," Siontis says. "It's a common problem in dialysis patients who generally have a lot of comorbidities. And the patients on dialysis who have Afib experience higher rates of stroke compared to patients with Afib who aren't on dialysis."

The present study was published in the journal Circulation.

Sources: National Kidney Foundation, Bristol-Myers Squibb, Michigan Medicine – University of Michigan

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
JUL 28, 2020
Cancer
Should you get your DNA test for community-based genetic screening?
JUL 28, 2020
Should you get your DNA test for community-based genetic screening?
In a new study published in the journal Nature Medicine, researchers champion the potential of community-based gene ...
AUG 07, 2020
Cardiology
CT Method Can Find New Ways to Improve CPR
AUG 07, 2020
CT Method Can Find New Ways to Improve CPR
The time it takes for a person experiencing cardiac arrest to get help can make the difference between life and death.
AUG 18, 2020
Cardiology
A Key Juncture Between Diabetes and Heart Repair
AUG 18, 2020
A Key Juncture Between Diabetes and Heart Repair
Patients with diabetes are often at increased cardiovascular risk. Recent research points to a possible new target for t ...
SEP 22, 2020
Cardiology
Mosquito-Borne Illnesses are Linked to Stroke
SEP 22, 2020
Mosquito-Borne Illnesses are Linked to Stroke
Mosquitoes are major disease vectors; they are considered the world's deadliest animal because they kill so many people.
OCT 06, 2020
Cardiology
A New Heart Drug Taken from a Yellow Dye
OCT 06, 2020
A New Heart Drug Taken from a Yellow Dye
Cardiovascular disease is an ever-present issue in the modern world.  One of the most unfortunate cardiovascular ev ...
OCT 15, 2020
Immunology
The Immune Cells Giving Menopausal Women Higher BPs
OCT 15, 2020
The Immune Cells Giving Menopausal Women Higher BPs
In general, men have higher blood pressures than women, giving them an increased risk of developing heart disease. After ...
Loading Comments...